Latest news and press releases about Thermo Fisher Scientific Inc. (TMO): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets.
Price
| Price | $676.76 |
| Market Cap | $250.2B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 35.22 |
| Price / Book | 4.61 |
| EV / EBITDA | 25.66 |
| Dividend Yield | 0.28% |
Profitability
| Return on Equity | 13.35% |
| Return on Invested Capital | 7.56% |
| Return on Assets | 6.17% |
| Gross Margin | 41.03% |
| Operating Margin | 17.97% |
| Net Margin | 15.06% |
Related companies: A · ABT · AMGN · AZN · DHR · IQV · ISRG
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of TMO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks